首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1274328

克隆和誘變全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Cloning And Mutagenesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年04月01日 | 出版商:

Value Market Research | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

在 2023 年至 2030 年的研究期間，全球對克隆和誘變市場的需求將以 10.52% 的複合年增長率增長，從 2022 年的 62.6 億美元增長到 2030 年的近 139.3 億美元，預計將達到規模。

克隆和誘變是指用於研究蛋白質功能、結構以及體外和體內突變影響的技術。克隆是一種涉及通過自然或人工手段創造複製品或相同生物體或實體的技術。它是使用生物技術方法完成的。誘變是一種改變生物體遺傳信息，導致基因突變的技術。它是通過在實驗室中操縱突變來在生物體中產生突變基因來完成的。克隆試劑盒用於基因治療、基因分析和生物製藥等各個領域。

市場動態：

慢性病和遺傳病患病率上升是推動克隆和誘變市場需求的主要因素。對個性化醫療不斷增長的需求促進了這一市場的增長。包括 PCR 在內的克隆和誘變工具的引入刺激了對該市場的需求。持續的技術創新、對用於藥物開發的蛋白質工程的日益關注以及對與 HIV 和癌症等疾病相關的研發投資的增加正在推動對該市場的需求。政府機構增加對醫學研究的資助、戰略合作以及全球生物技術行業的發展正在推動市場需求。

這份研究報告描述了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。此外，這些工具還能夠全面評估全球克隆和誘變市場的每個細分市場。克隆和誘變行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分：

克隆和誘變市場細分提供有關國家/地區級別細分的詳細數據，以確定每種產品/服務的目標受眾並支持未來的商機。

按產品

克隆試劑盒
誘變試劑盒
其他

技術

TopoPCR 克隆
平端克隆
無縫克隆
定點誘變
其他

由最終用戶

生物製藥和製藥公司
首席風險官/首席營銷官
學術和研究機構

按地區分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲的克隆和誘變市場當前和未來的需求。此外，該報告重點關注所有主要地區每個單獨應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。克隆和誘變市場的主要參與者是 Takara Bio Inc.、Agilent Technologies Inc.、Thermo Fisher Scientific Inc.、New England Biolabs、Merck KGaA、Promega Corporation、Bio-Rad Laboratories Inc、Danaher、Jena Bioscience GmbH，這三個公司是 Assay Genie 和 TransGen Biotech Co. Ltd. 本節包括對競爭格局的全面了解，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

內容

第一章前言

本報告的內容
- 目的
- 目標受眾
- 獨特的銷售建議 (USP) 和提供的服務
調查範圍
調查方法
- 市場調研過程
- 市場研究方法

第 2 章執行摘要

市場亮點
全球市場概況

第3章克隆與誘變-行業分析

簡介 - 市場動態
市場驅動因素
市場製約因素
市場機會
行業趨勢
波特的五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 按技術進行市場吸引力分析
- 按市場進行的吸引力分析：按最終用戶
- 市場吸引力分析：按地區

第四章價值鏈分析

價值鏈分析
原材料分析
- 成分錶
- 原材料製造商列表
- 主要原材料價格走勢
潛在買家名單
營銷渠道
- 直接營銷
- 間接營銷
- 營銷渠道趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章克隆和突變全球產品市場分析

產品概覽
實際數據和預測數據
按產品分析
克隆試劑盒
誘變試劑盒
其他

第 7 章克隆和誘變全球市場分析：按技術分類

技術概述
歷史和預測數據
技術分析
拓撲聚合□鏈反應克隆
平端克隆
無縫克隆
定點誘變
其他

第 8 章最終用戶的全球克隆和誘變劑加工市場銷售分析

最終用戶總結
實際數據和預測數據
最終用戶分析
生物製藥和製藥公司
首席風險官/首席營銷官
學術和研究機構

第 9 章按地區分列的克隆和誘變市場全球銷售分析

按地區進行的銷售前景分析
介紹銷售分析
北美銷售分析
- 概覽、歷史和預測銷售分析
- 北美各部門的銷售分析
- 北美銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史和預測銷售分析
- 按細分市場進行的歐洲銷售分析
- 按國家/地區劃分的歐洲銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 意大利銷售分析
- 俄羅斯銷售分析
- 其他歐洲銷售分析
亞太地區銷售分析
- 概覽、歷史和未來銷售分析
- 亞太地區各部門的銷售分析
- 亞太國家/地區銷售分析
- 在中國的銷售分析
- 印度銷售分析
- 日本的銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 其他亞太地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史和未來銷售分析
- 拉丁美洲各部門的銷售分析
- 拉丁美洲國家/地區的銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利的銷售分析
- 其他拉丁美洲銷售分析
中東和非洲銷售分析
- 概覽、歷史和未來銷售分析
- 中東/非洲地區的銷售分析
- 中東和非洲國家/地區的銷售分析
- 沙特阿拉伯銷售分析
- 阿聯酋銷售分析
- 以色列銷售分析
- 南非銷售分析
- 其他中東和非洲銷售分析

第10章克隆誘變公司的競爭格局

克隆誘變市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第11章公司簡介

前 10 名公司的市場份額分析
市場集中度
Takara Bio Inc.
- 公司簡介
- 企業收入
- 產品介紹
- 近期發展狀況
安捷倫科技公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
Thermo Fisher Scientific Inc.
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
新英格蘭生物實驗室
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
默克公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
普羅米加公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
Bio-Rad 實驗室公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
丹納赫
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
耶拿生物科學有限公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
化驗精靈
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
TransGen Biotech Co. Ltd.
- 公司簡介
- 企業收入
- 產品信息
- 近期趨勢

注意：公司簡介中的財務細節和近期發展基於可用信息，可能不包括私營公司。

簡介目錄圖表

Product Code: VMR112110321

The global demand for Cloning And Mutagenesis Market is presumed to reach the market size of nearly USD 13.93 BN by 2030 from USD 6.26 BN in 2022 with a CAGR of 10.52% under the study period 2023 - 2030.

Cloning and mutagenesis refer to the techniques used to study the functions or structure of proteins and the effect of a mutation in vitro and in vivo. Cloning is a technique which includes the creation of a replica or identical organism or entity by natural or artificial means. It is done with the help of biotechnology methods. Mutagenesis is a technique in which the genetic information of an organism is altered and results in the mutation of genes. It is performed in the lab where mutations are engineered to produce mutant genes of an organism. Cloning kits are used in various fields, such as gene therapy, gene analysis, biopharmaceutical, etc.

Market Dynamics:

The rising prevalence of chronic and genetic diseases is the key factor driving the demand for cloning and the mutagenesis market. Growing demand for personalized medicines is contributing to the growth of this market. The adoption of cloning and mutagenesis tools, including PCR is surging the demand for this market. Continuous innovation in technology, coupled with a rising focus on protein engineering for drug development and growing investment in research and development associated with diseases like HIV and cancer, are propelling the demand for this market. Rising funding by government organizations for medical research, strategic collaborations and the rise in biotechnology industries all over the world are boosting the demand for this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cloning and mutagenesis. The growth and trends of cloning and mutagenesis industry provide a holistic approach to this study.

Market Segmentation:

This section of the cloning and mutagenesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Cloning Kits
Mutagenesis Kits
Others

By Technology

Topo PCR Cloning
Blunt End Cloning
Seamless Cloning
Site-Directed Mutagenesis
Others

By End-User

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cloning And Mutagenesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cloning and mutagenesis market include Takara Bio Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CLONING AND MUTAGENESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CLONING AND MUTAGENESIS MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Cloning Kits Historic and Forecast Sales by Regions
6.5 Mutagenesis Kits Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLONING AND MUTAGENESIS MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Topo PCR Cloning Historic and Forecast Sales by Regions
7.5 Blunt End Cloning Historic and Forecast Sales by Regions
7.6 Seamless Cloning Historic and Forecast Sales by Regions
7.7 Site-directed Mutagenesis Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLONING AND MUTAGENESIS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Biopharmaceutical & Pharmaceutical Companies Historic and Forecast Sales by Regions
8.5 CROs & CMOs Historic and Forecast Sales by Regions
8.6 Academic & Research Institutes Historic and Forecast Sales by Regions

9 . GLOBAL CLONING AND MUTAGENESIS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLONING AND MUTAGENESIS COMPANIES

10.1. Cloning And Mutagenesis Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CLONING AND MUTAGENESIS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Takara Bio Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Agilent Technologies Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. New England Biolabs
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Promega Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Bio-Rad Laboratories Inc.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Danaher
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Jena Bioscience GmbH
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Assay Genie
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. TransGen Biotech Co. Ltd.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表